Navigation Links
Significant reductions in mortality shown using blood pressure-lowering treatment in very elderly
Date:3/31/2008

Lowering the blood pressure of elderly patients could cut their total mortality by a fifth and their rate of cardiovascular events by a third, according to a new study presented today (Monday 31 March) at the American College of Cardiology in Chicago and published simultaneously in the New England Journal of Medicine.

The 3,845 patient Hypertension in the Very Elderly Trial (HYVET), which is coordinated by scientists from Imperial College London, is the largest ever clinical trial to look at the effects of lowering blood pressure solely in those aged 80 and over. Patients were given either a placebo or the diuretic indapamide slow release (SR) 1.5mg, with the addition of the ACE inhibitor perindopril in tablet form once a day.

The research shows that the benefits of treatment include a 21% (p=0.02) reduction in total mortality rate, a 39% (p=0.05) reduction in stroke mortality rate, a 64% (p<0.001) reduction in fatal and non-fatal heart failures and a 34% (p<0.001) reduction in cardiovascular events. The benefits were apparent within the first year of follow-up.

The reduction in overall mortality was a novel and unexpected result. Earlier trials had demonstrated that reducing blood pressure in the under-80s reduces stroke and cardiovascular events. However, previous smaller and inconclusive studies also suggested that whilst lowering blood pressure in those aged 80 or over reduced the number of strokes, it did not reduce, and even possibly increased, total mortality.

In July 2007 the trial was stopped early on the recommendation of an independent data monitoring committee after they observed significant reductions in overall mortality and stroke in those receiving treatment. The final results of the trial showed a significant reduction in stroke mortality rate, but the reduction in all strokes of 30% did not quite reach statistical significance (p=0.06) In those aged 80 and over, up to half of strokes are fatal and the red
'/>"/>

Contact: Laura Gallagher
L.Gallagher@imperial.ac.uk
44-078-038-86248
Imperial College London
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. MedCom Announces Card Activation Wins Significant Court Ruling
2. Significant Generic Erosion Will Cause Sales of Dyslipidemia Drugs to Decline by $3.6 Billion by 2016
3. Carnegie Mellon study shows just listening to cell phones significantly impairs drivers
4. NeurogesX to Present at Susquehanna Financial Groups 2nd Annual SIGnificant Options in Healthcare Conference
5. Novavax CEO to Present at Susquehannas Second SIGnificant Options in Healthcare Conference
6. Abaxis, Inc. to Present at the Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
7. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
8. Advanced Life Sciences to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference
9. Significant Growth for Pinstripe Leads to Need for Larger Facility
10. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
11. AAAS symposium to address significant effects of the male parent in reproductive success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)--In Youngest Babies, This Type of Blood Cancer Is Most Challenging-- ,, PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse w
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/5/2009)The MAMA campaign is a collaborative effort by the National Association of Certified Professional Midwives (NACPM), Midwives Alliance of North America (MANA), Citizens for Midwifery (CfM), Internation
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
Breaking Medicine News(10 mins):Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 2Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 3Health News:AquaNatal Birth Center Gives Away a Waterbirth Package to Celebrate the Successful MAMA Campaign 4Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
...s today filed an appeal in their challenge of a co...eld by the Wisconsin Alumni Research,Foundation (W... for Taxpayer and Consumer,Rights, and the Public ...s requested a re-examination of the patent,in July...
...nnipeg (July 18, 2008) Funding of $4.4 million fr...R) was announced today by Steven Fletcher, MP for ... Secretary for Health, on behalf of Tony Clement, ...Health Commission of Canada is contributing $250,0...
...chigan State University scholar refutes commonly h..., more emotionally unstable and harder to get alon...ith the findings, employers are urged to guard aga...ent, and two colleagues studied the relationship b...
...paign to raise awareness, of the importance of t... compliance rates across the United St...ation, a,nonprofit organization dedicated to healt...ay, July 19 in conjunction,with the Ebenezer Afric...
...eld,United Concordia Companies, Inc. and Catholic ...es and lifestyles for Pittsburghers. Beginning at ...y 19, a free clinic will,offer health information ...re than other aspects of health care. The percepti...
...t old drug offers new hope , , FRIDAY, Jul...ne step back in the search for treatments against ...e July 19 issue of The Lancet , an older drug cal...er,s -- even though it cleared dementia-linked amy...
Other Medicine News:Health News:Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF 2Health News:CIHR announces $4.4 million to improve mental health of Canadians 2Health News:Studies refute common stereotypes about obese workers 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 3Health News:Highmark Blue Cross Blue Shield, United Concordia and Catholic Charities Join Forces to Offer Free Health, Dental Services This Saturday 2Health News:Alzheimer's Research Brings Progress, Setbacks 2Health News:Alzheimer's Research Brings Progress, Setbacks 3Health News:Alzheimer's Research Brings Progress, Setbacks 4
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 1ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 2ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 3ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 4ViroPharma Receives Complete Response Letter for Cinryze 28TM 29 Supplemental Biologics License Application for Acute Treatment of Hereditary Angioede 12463 5EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 1EUCODIS Bioscience Launches Beta Lactamase for Antibiotics and Diagnostics Industries 12462 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 1Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 2Cardiac Science to Present at Needham Biotechnology 26 Medical Technology Conference 47874 3
Whelan-Moss T-Tube
Double round silicone drain with trocar
Siliconized PVC drains
Trocar Sheath Needle
Medicine Products: